Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination antihypertensive drugs: recommendations for use.

N S Skolnik1, J D Beck, M Clark

  • 1Abington Memorial Hospital, Jenkintown, Pennsylvania, USA.

American Family Physician
|June 6, 2000
PubMed
Summary

Low-dose beta blockers or diuretics are recommended first-line hypertension treatments. Single-dose combination therapy offers improved blood pressure control and compliance, with fewer side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CIMT 2023: report on the 20th Annual Meeting of the Association for Cancer Immunotherapy.

Immuno-oncology technology·2023
Same author

Phenotype Harmonization in the GLIDE2 Oral Health Genomics Consortium.

Journal of dental research·2022
Same author

Periodontal Medicine: 100 Years of Progress.

Journal of dental research·2019
Same author

[Not Available].

Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege·2018
Same author

Effects of Maternal Campylobacter rectus Infection on Murine Placenta, Fetal and Neonatal Survival, and Brain Development.

Journal of periodontology·2018
Same author

Racial differences in periodontal disease and 10-year self-reported tooth loss among late middle-aged and older adults: the dental ARIC study.

Journal of public health dentistry·2017

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • First-line hypertension therapy often involves low-dose beta blockers or diuretics.
  • Monotherapy achieves target blood pressure (<140/90 mm Hg) in only about 50% of patients.
  • Multiple agents from different classes are frequently required for adequate blood pressure management.

Purpose of the Study:

  • To highlight the benefits of single-dose combination antihypertensive therapy.
  • To emphasize its efficacy, low side effect profile, and convenience for patient compliance.

Main Methods:

  • Review of pharmacologic classes used in combination antihypertensive therapy.
  • Analysis of combination therapy's role in achieving blood pressure control.

Main Results:

  • Single-dose combination therapy enhances blood pressure reduction efficacy.
  • It offers a favorable side effect profile and convenient once-daily dosing.
  • Combination options include diuretics with potassium-sparing diuretics, beta blockers, ACE inhibitors, angiotensin-II antagonists, and calcium channel blockers.

Conclusions:

  • Single-dose combination antihypertensive therapy is a valuable strategy.
  • It improves patient compliance and achieves better blood pressure control.
  • This approach addresses the limitations of monotherapy in hypertension management.

Related Experiment Videos